跳至主要内容
临床试验/NCT01715428
NCT01715428已完成不适用

Effects of Liraglutide on Cardio-Metabolic Risk Markers

University of Palermo1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
carotid intima-media thickness

研究概览

简要总结

Incretin-based therapies have shown significant effects beyond those on glucose metabolism. We aim in the present study to evaluate the effects of liraglutide on several cardio-metabolic risk markers.

详细描述

In details, we will evaluate the effects of liraglutide on carotid-intima media thickness, oxidative stress, ghrelin, heat shock proteins and lipoproteins.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with a diagnosis of type-2 diabetes

排除标准

  • severe hepatic or renal diseases

结局指标

主要结局

carotid intima-media thickness

时间窗: every four months for a total period of 2 years

carotid intima-media thickness will be assessed by doppler ultrasonography

次要结局

  • changes in plasma ghrelin concentrations and heat-shock proteins(after 2 months of therapy)
  • changes in oxidative stress markers(after 2 months of therapy)
  • changes in atherogenic lipoproteins(after 2 and after 4 months of therapy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Manfredi Rizzo

Assistant Professor

University of Palermo

研究点 (1)

Loading locations...

相似试验

Liraglutide and Cardio-Metabolic Risk Markers | 临床试验